Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Knific Duo from US lecture and perform at OSM
2017-05-12

Description: ' 000 Knific Duo Tags: Knific Duo

Profs Tom Knific and Renata Artman Knific from the Western
Michigan University School of Music are visiting the Odeion
School of Music at the University of the Free State.
Photo: Supplied

The renowned Knific Duo will not only perform at the University of the Free State (UFS) soon, but will also share their expertise at the Odeion School of Music (OSM). The duo, consisting of Profs Tom Knific and Renata Artman Knific, from the prestigious Western Michigan University School of Music, are presenting a masterclass series hosted by the OSM Concert Agency. The series takes place from 10-14 May 2017 and the concert on 16 May 2017.

Concert features local pianists

The first half of the concert on 16 May 2017 will present a programme leaning towards the classical genre. Apart from three works composed by Prof Knific, it will also include two movements from the Violin Sonata by the Hungarian composer Miklós Rózsa. 
In the second half Prof Knific will collaborate with two local pianists, the legendary jazz pianist, composer and music educator, Noel Stockton, and the talented Andile Qongqo, and for a carefully curated jazz programme mainly from the oeuvre of Prof Knific. Random Dreams, a work composed by Stockton will also be included.

Well-known around the world

Prof Knific (double bass) is a Professor at the Department of Jazz at the Western Michigan University School of Music. He has been principal bassist of orchestras from the US to Europe and performed as a soloist and in chamber music festivals around the world. He also is a former president of the International Society of Bassists.

Prof Artman Knific (violin) is a professor of violin at the same institution. Her international career began in London at 21 when she joined the English Chamber Orchestra. Tours of Europe, North and South America and Asia followed where she collaborated with artists such as Herman Bauman and Isaac Stern. She has worked with conductors such as Daniel Barenboim and Christoph Eschenbach, and recorded records for EMI, Decca, and CBS labels.
 
Date: 16 May 2017
Time: 19:30
Place: Odeion (Bloemfontein Campus)

Musicians interested in masterclasses can contact Ninette Pretorius at  pretoriusn@ufs.ac.za

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept